Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 158

1.

Focal Therapy Eligibility Determined by Magnetic Resonance Imaging/Ultrasound Fusion Biopsy.

Nassiri N, Chang E, Lieu P, Priester AM, Margolis DJA, Huang J, Reiter RE, Dorey FJ, Marks LS, Natarajan S.

J Urol. 2018 Feb;199(2):453-458. doi: 10.1016/j.juro.2017.08.085. Epub 2017 Aug 19.

2.

Value of Tracking Biopsy in Men Undergoing Active Surveillance of Prostate Cancer.

Chang E, Jones TA, Natarajan S, Sharma D, Simopoulos D, Margolis DJ, Huang J, Dorey FJ, Marks LS.

J Urol. 2018 Jan;199(1):98-105. doi: 10.1016/j.juro.2017.07.038. Epub 2017 Jul 18.

3.

Targeted Biopsy to Detect Gleason Score Upgrading during Active Surveillance for Men with Low versus Intermediate Risk Prostate Cancer.

Nassiri N, Margolis DJ, Natarajan S, Sharma DS, Huang J, Dorey FJ, Marks LS.

J Urol. 2017 Mar;197(3 Pt 1):632-639. doi: 10.1016/j.juro.2016.09.070. Epub 2016 Sep 14.

4.

Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: The role of systematic and targeted biopsies.

Filson CP, Natarajan S, Margolis DJ, Huang J, Lieu P, Dorey FJ, Reiter RE, Marks LS.

Cancer. 2016 Mar 15;122(6):884-92. doi: 10.1002/cncr.29874. Epub 2016 Jan 7.

5.

Initial experience with electronic tracking of specific tumor sites in men undergoing active surveillance of prostate cancer.

Sonn GA, Filson CP, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS.

Urol Oncol. 2014 Oct;32(7):952-7. doi: 10.1016/j.urolonc.2014.04.003. Epub 2014 Jul 11.

6.

Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathology.

Le JD, Stephenson S, Brugger M, Lu DY, Lieu P, Sonn GA, Natarajan S, Dorey FJ, Huang J, Margolis DJ, Reiter RE, Marks LS.

J Urol. 2014 Nov;192(5):1367-73. doi: 10.1016/j.juro.2014.04.094. Epub 2014 May 1.

7.

Targeted prostate biopsy in select men for active surveillance: do the Epstein criteria still apply?

Hu JC, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Sonn G, Dorey FJ, Marks LS.

J Urol. 2014 Aug;192(2):385-90. doi: 10.1016/j.juro.2014.02.005. Epub 2014 Feb 8.

8.

Outcome of chronic isolated anterior cruciate ligament reconstruction.

McAllister DR, Foster B, Martin DE, Veitch AJ, Dorey FJ, Petrigliano F, Hame SL.

J Knee Surg. 2014 Oct;27(5):383-92. doi: 10.1055/s-0033-1364099. Epub 2014 Jan 17.

PMID:
24443288
9.

Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen.

Sonn GA, Chang E, Natarajan S, Margolis DJ, Macairan M, Lieu P, Huang J, Dorey FJ, Reiter RE, Marks LS.

Eur Urol. 2014 Apr;65(4):809-15. doi: 10.1016/j.eururo.2013.03.025. Epub 2013 Mar 17.

10.

Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device.

Sonn GA, Natarajan S, Margolis DJ, MacAiran M, Lieu P, Huang J, Dorey FJ, Marks LS.

J Urol. 2013 Jan;189(1):86-91. doi: 10.1016/j.juro.2012.08.095. Epub 2012 Nov 14.

11.

Do ion concentrations after metal-on-metal hip resurfacing increase over time? A prospective study.

Amstutz HC, Campbell PA, Dorey FJ, Johnson AJ, Skipor AK, Jacobs JJ.

J Arthroplasty. 2013 Apr;28(4):695-700. doi: 10.1016/j.arth.2012.07.040. Epub 2012 Nov 2.

PMID:
23123040
12.

Racial disparity in fracture risk between white and nonwhite children in the United States.

Wren TA, Shepherd JA, Kalkwarf HJ, Zemel BS, Lappe JM, Oberfield S, Dorey FJ, Winer KK, Gilsanz V.

J Pediatr. 2012 Dec;161(6):1035-40. doi: 10.1016/j.jpeds.2012.07.054. Epub 2012 Sep 10.

13.

Type II supracondylar humerus fractures: can some be treated nonoperatively?

Spencer HT, Dorey FJ, Zionts LE, Dichter DH, Wong MA, Moazzaz P, Silva M.

J Pediatr Orthop. 2012 Oct-Nov;32(7):675-81. doi: 10.1097/BPO.0b013e318269c459.

PMID:
22955530
14.

Inverse association between brown adipose tissue activation and white adipose tissue accumulation in successfully treated pediatric malignancy.

Chalfant JS, Smith ML, Hu HH, Dorey FJ, Goodarzian F, Fu CH, Gilsanz V.

Am J Clin Nutr. 2012 May;95(5):1144-9. doi: 10.3945/ajcn.111.030650. Epub 2012 Mar 28.

15.

Bone marrow fat is inversely related to cortical bone in young and old subjects.

Wren TA, Chung SA, Dorey FJ, Bluml S, Adams GB, Gilsanz V.

J Clin Endocrinol Metab. 2011 Mar;96(3):782-6. doi: 10.1210/jc.2010-1922. Epub 2010 Dec 22.

PMID:
21177790
16.

Functional brown adipose tissue is related to muscle volume in children and adolescents.

Gilsanz V, Chung SA, Jackson H, Dorey FJ, Hu HH.

J Pediatr. 2011 May;158(5):722-6. doi: 10.1016/j.jpeds.2010.11.020. Epub 2010 Dec 18.

17.

Bone density and size in ambulatory children with cerebral palsy.

Al Wren T, Lee DC, Kay RM, Dorey FJ, Gilsanz V.

Dev Med Child Neurol. 2011 Feb;53(2):137-41. doi: 10.1111/j.1469-8749.2010.03852.x. Epub 2010 Dec 17.

18.

Effect of high-frequency, low-magnitude vibration on bone and muscle in children with cerebral palsy.

Wren TA, Lee DC, Hara R, Rethlefsen SA, Kay RM, Dorey FJ, Gilsanz V.

J Pediatr Orthop. 2010 Oct-Nov;30(7):732-8. doi: 10.1097/BPO.0b013e3181efbabc.

19.

Statistics in brief: Statistical power: what is it and when should it be used?

Dorey FJ.

Clin Orthop Relat Res. 2011 Feb;469(2):619-20. doi: 10.1007/s11999-010-1435-0. No abstract available.

20.

Stromelysin-1 (MMP-3) is a target and a regulator of Wnt1-induced epithelial-mesenchymal transition (EMT).

Blavier L, Lazaryev A, Shi XH, Dorey FJ, Shackleford GM, DeClerck YA.

Cancer Biol Ther. 2010 Jul 15;10(2):198-208. Epub 2010 Jul 29.

21.

In brief: statistics in brief: Confidence intervals: what is the real result in the target population?

Dorey FJ.

Clin Orthop Relat Res. 2010 Nov;468(11):3137-8. doi: 10.1007/s11999-010-1407-4. No abstract available.

22.

Activity recommendations after total hip and knee arthroplasty: a survey of the American Association for Hip and Knee Surgeons.

Swanson EA, Schmalzried TP, Dorey FJ.

J Arthroplasty. 2009 Sep;24(6 Suppl):120-6. doi: 10.1016/j.arth.2009.05.014.

PMID:
19698910
23.

Reciprocal relations of subcutaneous and visceral fat to bone structure and strength.

Gilsanz V, Chalfant J, Mo AO, Lee DC, Dorey FJ, Mittelman SD.

J Clin Endocrinol Metab. 2009 Sep;94(9):3387-93. doi: 10.1210/jc.2008-2422. Epub 2009 Jun 16.

24.

Quantitative CT reference values for vertebral trabecular bone density in children and young adults.

Gilsanz V, Perez FJ, Campbell PP, Dorey FJ, Lee DC, Wren TA.

Radiology. 2009 Jan;250(1):222-7. doi: 10.1148/radiol.2493080206. Epub 2008 Nov 10.

25.

Reproducibility of carotid intima-media thickness measurements in young adults.

Gonzalez J, Wood JC, Dorey FJ, Wren TA, Gilsanz V.

Radiology. 2008 May;247(2):465-71. doi: 10.1148/radiol.2472070691. Epub 2008 Mar 18.

PMID:
18349312
26.

Symptomatic osteonecrosis of the hip and knee after cardiac transplantation.

Lieberman JR, Roth KM, Elsissy P, Dorey FJ, Kobashigawa JA.

J Arthroplasty. 2008 Jan;23(1):90-6. doi: 10.1016/j.arth.2007.01.006.

PMID:
18165036
27.

Metal-on-metal hip resurfacing for obese patients.

Le Duff MJ, Amstutz HC, Dorey FJ.

J Bone Joint Surg Am. 2007 Dec;89(12):2705-11.

PMID:
18056503
28.

Gillette Gait Index as a gait analysis summary measure: comparison with qualitative visual assessments of overall gait.

Wren TA, Do KP, Hara R, Dorey FJ, Kay RM, Otsuka NY.

J Pediatr Orthop. 2007 Oct-Nov;27(7):765-8.

PMID:
17878782
29.

The effects of technique changes on aseptic loosening of the femoral component in hip resurfacing. Results of 600 Conserve Plus with a 3 to 9 year follow-up.

Amstutz HC, Le Duff MJ, Campbell PA, Dorey FJ.

J Arthroplasty. 2007 Jun;22(4):481-9. Epub 2007 Mar 28.

PMID:
17562402
30.

Obesity and outcome in pediatric acute lymphoblastic leukemia.

Butturini AM, Dorey FJ, Lange BJ, Henry DW, Gaynon PS, Fu C, Franklin J, Siegel SE, Seibel NL, Rogers PC, Sather H, Trigg M, Bleyer WA, Carroll WL.

J Clin Oncol. 2007 May 20;25(15):2063-9.

PMID:
17513811
31.

Death in patients with recurrent prostate cancer after radical prostatectomy: prostate-specific antigen doubling time subgroups and their associated contributions to all-cause mortality.

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW.

J Clin Oncol. 2007 May 1;25(13):1765-71.

PMID:
17470867
32.

Resurfacing THA for patients younger than 50 year: results of 2- to 9-year followup.

Amstutz HC, Ball ST, Le Duff MJ, Dorey FJ.

Clin Orthop Relat Res. 2007 Jul;460:159-64.

PMID:
17310929
33.

The femoral head/neck offset and hip resurfacing.

Beaulé PE, Harvey N, Zaragoza E, Le Duff MJ, Dorey FJ.

J Bone Joint Surg Br. 2007 Jan;89(1):9-15.

PMID:
17259408
34.

Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial.

Marks LS, Mazer NA, Mostaghel E, Hess DL, Dorey FJ, Epstein JI, Veltri RW, Makarov DV, Partin AW, Bostwick DG, Macairan ML, Nelson PS.

JAMA. 2006 Nov 15;296(19):2351-61.

PMID:
17105798
35.

Metal-on-metal hybrid surface arthroplasty. Surgical Technique.

Amstutz HC, Beaulé PE, Dorey FJ, Le Duff MJ, Campbell PA, Gruen TA.

J Bone Joint Surg Am. 2006 Sep;88 Suppl 1 Pt 2:234-49.

PMID:
16951096
36.

Prostatic tissue testosterone and dihydrotestosterone in African-American and white men.

Marks LS, Hess DL, Dorey FJ, Macairan ML.

Urology. 2006 Aug;68(2):337-41.

PMID:
16904448
37.

The value of patient activity level in the outcome of total hip arthroplasty.

Beaulé PE, Dorey FJ, Hoke R, Le Duff M, Amstutz HC.

J Arthroplasty. 2006 Jun;21(4):547-52.

PMID:
16781408
38.

Effects of busulfan dose escalation on engraftment of infant rhesus monkey hematopoietic stem cells after gene marking by a lentiviral vector.

Kahl CA, Tarantal AF, Lee CI, Jimenez DF, Choi C, Pepper K, Petersen D, Fletcher MD, Leapley AC, Fisher J, Burns TS, Ultsch MN, Dorey FJ, Kohn DB.

Exp Hematol. 2006 Mar;34(3):369-81.

PMID:
16543071
39.

Function and well-being in ambulatory children with cerebral palsy.

Pirpiris M, Gates PE, McCarthy JJ, D'Astous J, Tylkowksi C, Sanders JO, Dorey FJ, Ostendorff S, Robles G, Caron C, Otsuka NY.

J Pediatr Orthop. 2006 Jan-Feb;26(1):119-24.

PMID:
16439915
40.

Activity sampling in the assessment of patients with total joint arthroplasty.

Silva M, McClung CD, Dela Rosa MA, Dorey FJ, Schmalzried TP.

J Arthroplasty. 2005 Jun;20(4):487-91.

PMID:
16124965
41.

Risk of prostate cancer-specific mortality following biochemical recurrence after radical prostatectomy.

Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Dorey FJ, Walsh PC, Partin AW.

JAMA. 2005 Jul 27;294(4):433-9.

PMID:
16046649
42.

Proximal interphalangeal joint stiffness: measurement and analysis.

Dionysian E, Kabo JM, Dorey FJ, Meals RA.

J Hand Surg Am. 2005 May;30(3):573-9.

PMID:
15925170
43.

Three-dimensional computed tomography of the hip in the assessment of femoroacetabular impingement.

Beaulé PE, Zaragoza E, Motamedi K, Copelan N, Dorey FJ.

J Orthop Res. 2005 Nov;23(6):1286-92.

44.

Metal-on-metal surface arthroplasty with a cemented femoral component: a 7-10 year follow-up study.

Beaulé PE, Le Duff M, Campbell P, Dorey FJ, Park SH, Amstutz HC.

J Arthroplasty. 2004 Dec;19(8 Suppl 3):17-22.

PMID:
15578547
45.

Symptoms as well as tumor size provide prognostic information on patients with localized renal tumors.

Patard JJ, Dorey FJ, Cindolo L, Ficarra V, De La Taille A, Tostain J, Artibani W, Abbou CC, Lobel B, Chopin DK, Figlin RA, Belldegrun AS, Pantuck AJ.

J Urol. 2004 Dec;172(6 Pt 1):2167-71.

PMID:
15538224
46.

Prostate cancer in native Japanese and Japanese-American men: effects of dietary differences on prostatic tissue.

Marks LS, Kojima M, Demarzo A, Heber D, Bostwick DG, Qian J, Dorey FJ, Veltri RW, Mohler JL, Partin AW.

Urology. 2004 Oct;64(4):765-71.

PMID:
15491717
47.

Cystic renal cell carcinoma: biology and clinical behavior.

Han KR, Janzen NK, McWhorter VC, Kim HL, Pantuck AJ, Zisman A, Figlin RA, Dorey FJ, Said JW, Belldegrun AS.

Urol Oncol. 2004 Sep-Oct;22(5):410-4.

PMID:
15464922
48.

Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study.

Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A, Ficarra V, Han KR, Cindolo L, De La Taille A, Tostain J, Artibani W, Dinney CP, Wood CG, Swanson DA, Abbou CC, Lobel B, Mulders PF, Chopin DK, Figlin RA, Belldegrun AS.

J Clin Oncol. 2004 Aug 15;22(16):3316-22.

PMID:
15310775
49.

Use of American Society of Anesthesiologists physical status classification to assess perioperative risk in patients undergoing radical nephrectomy for renal cell carcinoma.

Han KR, Kim HL, Pantuck AJ, Dorey FJ, Figlin RA, Belldegrun AS.

Urology. 2004 May;63(5):841-6; discussion 846-7.

PMID:
15134960
50.

Risk factors affecting outcome of metal-on-metal surface arthroplasty of the hip.

Beaulé PE, Dorey FJ, Le Duff MJ, Gruen T, Amstutz HC.

Clin Orthop Relat Res. 2004 Jan;(418):87-93. Erratum in: Clin Orthop Relat Res. 2011 Sep;469(9):2658. LeDuff, Michel [corrected to Le Duff, Michel J].

PMID:
15043098

Supplemental Content

Loading ...
Support Center